24/7 Market News Snapshot 09 July, 2025 – Candel Therapeutics, Inc. Common Stock (NASDAQ:CADL)

July 9, 2025

DENVER, Colo., 09 July, 2025 (www.247marketnews.com) – (Nasdaq:CADL) are discussed in this article.
Candel Therapeutics, Inc. (Nasdaq:CADL), a dynamic clinical-stage biopharmaceutical firm focused on groundbreaking biological immunotherapies for cancer treatment, has demonstrated a significant uptick in its stock performance today. Opening at $5.34, shares have surged to $6.03, representing an impressive 15.08% increase since the previous close of $5.24. With a trading volume surpassing 1.44 million shares, investor interest continues to grow, possibly influenced by favorable market sentiment or positive developments surrounding the company.

In a noteworthy announcement, Candel has secured its place in several Russell indexes during the upcoming reconstitution on June 30, 2025. This inclusion includes the Russell 2500 Value® Index, Russell Small Cap Value® Index, Russell 2000 Value® Index, Russell Microcap Value® Index, and the Russell 3000E® Value Index. Notably, Candel also continues its representation in the Russell 3000® Index, a feat achieved for the first time in 2024.

Paul Peter Tak, M.D., Ph.D., FMedSci, President and CEO of Candel, remarked on this recognition, emphasizing the company’s ongoing progress in clinical initiatives and their dedication to innovative cancer therapies. He highlighted the impending submission of a Biologics License Application and pre-commercialization efforts for CAN-2409, targeting localized prostate cancer, as pivotal steps for Candel.

The Russell indexes, with more than $10.6 trillion in assets benchmarked against them, play a vital role for investment managers and institutional investors and serve as critical tools for guiding investment strategies. Candel is committed to pioneering off-the-shelf immunotherapies aimed at eliciting substantial anti-tumor responses, reaffirming its dedication to addressing the significant unmet medical needs within the oncology landscape.

Related news for (CADL)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.